Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Not all wealth building strategies are created equal. Discover the ones that truly work and can help you grow your finances effectively.
17,941 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A disciplined, six‑stock dividend plan could turn $100,000 into reliable annual income. Here's the latest layout, yie...
Base founder Jesse Pollak is stepping back from day-to-day leadership after acknowledging a failed social strategy. T...
A Republican senator signals his support may hinge on Todd Blanche meeting Epstein accusers, turning the confirmation...
June data reveal a surprising split: housing starts topped expectations while housing permits near cycle lows, hintin...
In the latest SOXX snapshot, AMD rises to the top while Nvidia slides to a close second and Micron inches closer. Lea...
When headlines shout that berkshire hathaway sold mastercard, investors feel the pull to imitate. This guide explains...
After the latest earnings, investors are weighing growth prospects, margins, and valuation for Domino's. This guide b...
A timing mishap reveals more than a celebrity scoop—it shows how quick news can ripple through budgets and plans. Thi...
XOVR, the $1.5 billion ETF that blends pre-IPO SpaceX exposure with public-growth stocks, is drawing renewed scrutiny...
Bloom Energy has surged 497% over the past year, shaking up portfolios and headlines. This guide breaks down what the...
January 2026 brings a shift in power toward buyers. Homes stay on the market longer, and sellers are more willing to ...